Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Neogenomics Inc Issues Q3 2013 Guidance; Revenue Guidance Below Analysts' Estimates; Issues FY 2013 Guidance; Revenue Guidance Below Analysts' Estimates


Wednesday, 31 Jul 2013 07:00am EDT 

Neogenomics Inc announced that for third Quarter of 2013, it expects revenue of $15.8 - $16.4 million and earnings of $0.00 - $0.01 per share. For the fiscal 2013, it expects revenue to be $63-$66 million with earnings per share of $.01 - $.04. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $68 million and EPS of $0.04 for fiscal 2013; revenue of $17.6 million and EPS of $0.01 for third quarter of 2013. 

Company Quote

4.79
0.26 +5.74%
1 May 2015